Monsanto gains technology from pharma company
Monsanto has agreed to collaborate with the Belgian biopharmaceutical company, Complix (Hasselt), on the application of Complix’s Alphabody technology in agriculture. Alphabodies are single-chain alpha-helical proteins that are designed by computer modelling. Monsanto believes that the technology could contribute to its development of new traits to protect plants from pests and diseases. Complix will grant Monsanto exclusive global rights to use the technology in “plant agriculture”, while the Belgian firm will retain rights in other areas. The agreement includes options to expand the collaboration across multiple applications within plant agriculture.